(Q36117074)

12 August 2017

1 reference

title

Vaccination against acute respiratory virus infections and measles in man (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1587542

11 October 2022

1 reference

1

Osterhaus AD

1 reference

12 August 2017

de Vries P

2

1 reference

12 August 2017

Osterhaus AD

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1587542

11 October 2022

language of work or name

1 reference

1 February 1992

1 reference

12 August 2017

1 reference

12 August 2017

volume

184

1 reference

12 August 2017

issue

2-3

1 reference

12 August 2017

page(s)

180-192

1 reference

An experimental influenza subunit vaccine (iscom): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980474-2

7 January 2021

IMMUNIZATION WITH LIVE ATTENUATED MEASLES VIRUS VACCINES: FIVE YEARS' EXPERIENCE.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980474-2

7 January 2021

Antibody response following measles-mumps-rubella vaccine under conditions of customary use

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980474-2

7 January 2021

Differences in the Appearance of Antibodies to Structural Components of Measles Virus after Immunization with Inactivated and Live Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980474-2

7 January 2021

Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980474-2

7 January 2021

Protection against canine distemper virus in dogs after immunization with isolated fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980474-2

7 January 2021

Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980474-2

7 January 2021

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980474-2

7 January 2021

Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980474-2

7 January 2021

Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980474-2

7 January 2021

Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980474-2

7 January 2021

Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980474-2

7 January 2021

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980474-2

7 January 2021

Expression of biologically active and antigenically authentic parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein by a recombinant baculovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980474-2

7 January 2021

Attenuation of bovine parainfluenza virus type 3 in nonhuman primates and its ability to confer immunity to human parainfluenza virus type 3 challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980474-2

7 January 2021

Parenteral inactivated rhinovirus vaccine: minimal protective effect

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980474-2

7 January 2021

Evidence for protective effect of an inactivated rhinovirus vaccine administered by the nasal route.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980474-2

7 January 2021

Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980474-2

7 January 2021

The iscom: an immunostimulating system

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980474-2

7 January 2021

10.1016/S0171-2985(11)80474-2

Identifiers

DOI

0 references

1 reference